Your browser doesn't support javascript.
loading
A Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial.
Alton, Eric W F W; Boyd, A Christopher; Porteous, David J; Davies, Gwyneth; Davies, Jane C; Griesenbach, Uta; Higgins, Tracy E; Gill, Deborah R; Hyde, Stephen C; Innes, J Alastair.
Afiliação
  • Alton EW; 1 Imperial College London London, United Kingdom.
  • Boyd AC; 3 Royal Brompton & Harefield NHS Foundation Trust London, United Kingdom.
  • Porteous DJ; 2 University of Edinburgh Edinburgh, United Kingdom.
  • Davies G; 2 University of Edinburgh Edinburgh, United Kingdom.
  • Davies JC; 1 Imperial College London London, United Kingdom.
  • Griesenbach U; 3 Royal Brompton & Harefield NHS Foundation Trust London, United Kingdom.
  • Higgins TE; 1 Imperial College London London, United Kingdom.
  • Gill DR; 3 Royal Brompton & Harefield NHS Foundation Trust London, United Kingdom.
  • Hyde SC; 1 Imperial College London London, United Kingdom.
  • Innes JA; 3 Royal Brompton & Harefield NHS Foundation Trust London, United Kingdom.
Am J Respir Crit Care Med ; 192(11): 1389-92, 2015 Dec 01.
Article em En | MEDLINE | ID: mdl-26623687
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Regulador de Condutância Transmembrana em Fibrose Cística / Fibrose Cística Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Regulador de Condutância Transmembrana em Fibrose Cística / Fibrose Cística Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article